1. |
宋光远, 王墨扬, 王媛, 等. Venus-A 主动脉瓣膜介入治疗重度主动脉瓣狭窄的效果. 中华心血管病杂志, 2017, 45(10): 843-847.
|
2. |
Hof A, Raschke S, Baier K, et al. Challenges in developing a reseeded, tissue-engineered aortic valve prosthesis. Eur J Cardiothorac Surg, 2016, 50(3): 446-455.
|
3. |
Silaschi M, Chaubey S, Aldalati O, et al. Is mitral valve repair superior to mitral valve replacement in elderly patients? comparison of shortand long-term outcomes in a propensity-matched cohort. J Am Heart Assoc, 2016, 5(8): e003605.
|
4. |
Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol, 2017, 70(2): 252-289.
|
5. |
王奇, 主编. 心血管外科. 北京: 中国科学技术出版社, 2015. 110-112.
|
6. |
项理, 刘一为, 黄源, 等. 复杂型先天性心脏病瓣膜成形术后中期生存结果和生活质量研究. 中国循环杂志, 2017, 32(z1): 159.
|
7. |
张李涛, 龙艳丽, 杨军, 等. D-二聚体水平与机械心脏瓣膜置换术后患者抗凝治疗中发生临床事件的关系. 中华心血管病杂志, 2017, 45(10): 852-856.
|
8. |
Bisson A, Bodin A, Clementy N, et al. Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification. Int J Cardiol, 2018, 260(6): 93-98.
|
9. |
Binder RK, Nietlispach F, Holubec T, et al. Percutaneous treatment of severe transvalvular and paravalvular regurgitation in a failing surgical aortic valve prosthesis due to recurrent endocarditis. Eur Heart J, 2016, 37(45): 3419-3424.
|
10. |
Breithardt G, Baumgartner H, Berkowitz SD, et al. Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban. Heart, 2016, 102(13): 1036-1043.
|
11. |
Poulin F, Yingchoncharoen T, Wilson WM, et al. Impact of prosthesis‐patient mismatch on left ventricular myocardial mechanics after transcatheter aortic valve replacement. J Am Heart Assoc, 2016, 5(2): e002866.
|
12. |
Carnicelli AP, O’Gara PT, Giugliano RP. Anticoagulation after heart valve replacement or transcatheter valve implantation. Am J Cardiol, 2016, 118(9): 1419-1426.
|
13. |
Head SJ, Çelik M, Kappetein AP. Mechanical versus bioprosthetic aortic valve replacement. Eur Heart J, 2017, 38(28): 2183-2191.
|
14. |
Lim G. Valvular disease: Mechanical versus biological valve prostheses. Nat Rev Cardiol, 2018, 15(1): 4-7.
|
15. |
Hellmeier F, Nordmeyer S, Yevtushenko P, et al. Hemodynamic evaluation of a biological and mechanical aortic valve prosthesis using patient-specific mri-based CFD. Artif Organs, 2018, 42(1): 49-57.
|
16. |
Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J, 2017, 38(36): 2739-2791.
|